Baguit, Julie Ann S.

HRN: 22-11-77  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2022
CEFUROXIME 750MG (VIAL)
10/27/2022
10/29/2022
IV
1.5gm X 6 Doses
Q8
UTI: Asymptomatic Bacteriuria
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  No Infection  No Infection

Overall appropriateness: No  No Infection

Intervention



Type of Intervention done:

                    

           


Acceptance: